Methadone Versus Buprenorphine for Treatment of Opioid Use Disorder

References

  • Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207. DOI: 10.1002/14651858.CD002207.pub4. PubMed PMID: 24500948.
  • Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. Jama Netw Open. 2020;3(2):e1920622. DOI: 10.1001/jamanetworkopen.2019.20622. PubMed PMID: 32022884; PubMed Central PMCID: PMC11143463.
  • Location of Medication-Assisted Treatment for Opioid Addiction: In Brief [Internet]. Congressional Research Service [published June 24, 2019; cited July 29, 2024]. Available from https://sgp.fas.org/crs/misc/R45782.pdf
  • Gudin J, Fudin J. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain. Pain Ther. 2020;9(1):41- 54. DOI: 10.1007/s40122-019-00143-6. PubMed PMID: 31994020; PubMed Central PMCID: PMC7203271.
  • Khail JW, Rawal S, Young HN, Caballero J. Addressing buprenorphine supply barriers: A guidance commentary. J Am Pharm Assoc (2003). 2024;64(2):377- 379. DOI: 10.1016/j.japh.2024.01.013. PubMed PMID: 38272311.
  • Ahmed S, Faruqui Z, Poddar K, Bhivandkar S, Suzuki J. Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions. J Opioid Management. 2023;19(5):455- 460. DOI: 10.5055/jom.0819. PubMed PMID: 37968979.
  • Spreen LA, Dittmar EN, Quirk KC, Smith MA. Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy. 2022;42(5):411- 427. DOI: 10.1002/phar.2676. PubMed PMID: 35302671; PubMed Central PMCID: PMC9310825.
  • D’Onofrio G, Hawk KF, Perron J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department-Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023 Mar;6(3):e236108.
  • Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstet Gynecol. 2017 Aug;130(2):e81-94.
  • Substance Abuse and Mental Health Administration. Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families. Treatment Improvement Protocol (TIP) Series, No. 63. Chapter 3B: Methadone; 2018. Accessed March 31, 2022. http://www.ncbi.nlm.nih.gov/books/NBK535269/
  • Baxter LES, Campbell A, DeShields M, et al. Safe Methadone Induction and Stabilization: Report of an Expert Panel. J Addict Med. 2013;7(6):377-386. doi:10.1097/01.ADM.0000435321.39251.d7